The Cellular Imaging Shared Resource (CISR) provides Consortium members with a comprehensive set of advanced high resolution imaging techniques, quantitative gel and blot imaging, and quantitative image analysis for cancer research. The resource is comprised of two service-based laboratories, Electron Microscopy (EM) and Scientific Imaging (SI). The EM laboratory offers sample preparation, access to microtomy, cryo- and immuno- EM technologies, and training in transmission and scanning EM, and atomic force microscopy. The SI laboratory provides access to advanced imaging systems for confocal, deconvolution, multi photon, time lapse, total internal reflection fluorescence, high content analysis, whole slide scanning, and other light microscopy techniques, along with powerful software for visualization and quantitative analysis of microscopy data. As research needs and priorities evolve, CI has expanded into new areas to provide support for a broader range of investigator and research programs. Examples of new services include: high content analysis and plate screening; whole slide scanning and analysis; and Cryo and Immuno-EM. Overall, all Consortium research programs currently use the resource and both components provide essential services and technologies for member research. The resource constantly evaluates new technologies and the benefits they can bring to the Consortium, and actively promotes the use of such technologies through classes, workshops, seminars, and one-on-one discussions with individual researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-44
Application #
9617705
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
44
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Ranola, John Michael O; Pearlman, Rachel; Hampel, Heather et al. (2018) Modified capture-recapture estimates of the number of families with Lynch syndrome in Central Ohio. Fam Cancer :
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580
Leger, Kasey J; Baker, K Scott; Cushing-Haugen, Kara L et al. (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124:1507-1515
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Dai, James Y; Liang, C Jason; LeBlanc, Michael et al. (2018) Case-only approach to identifying markers predicting treatment effects on the relative risk scale. Biometrics 74:753-763
Huang, Yijian; Wang, Ching-Yun (2018) Cox regression with dependent error in covariates. Biometrics 74:118-126
Syrjala, Karen L; Yi, Jean C; Artherholt, Samantha B et al. (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12:560-570
Hempstead, Bridgette; Green, Cynthia; Briant, Katherine J et al. (2018) Community Empowerment Partners (CEPs): A Breast Health Education Program for African-American Women. J Community Health 43:833-841
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Liu, Yanyan; Xiong, Sican; Sun, Wei et al. (2018) Joint Analysis of Strain and Parent-of-Origin Effects for Recombinant Inbred Intercrosses Generated from Multiparent Populations with the Collaborative Cross as an Example. G3 (Bethesda) 8:599-605

Showing the most recent 10 out of 1267 publications